Abstract Identifying molecular residual disease (MRD) after treatment of localized lung cancer could facilitate early intervention and personalization of adjuvant therapies. Here, we apply cancer personalized profiling by deep sequencing (CAPP-seq) circulating tumor DNA (ctDNA) analysis to 255 sampl...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!